Clinical trial
Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic…
NCT00108485 · University of Miami, Other · Terminated
Key facts
| NCT number | NCT00108485 |
|---|---|
| Title | Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy |
| Official title | Randomized, Double-blind, Placebo-controlled Trial of Niaspan® in Patients With Overt Diabetic Nephropathy and Moderate Renal Impairment |
| Lead sponsor | University of Miami, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2, Kidney Failure, Chronic, Hyperlipidemia |
| Intervention type | Drug, Other |
| Interventions | Extended release niacin, Placebo |
| Enrollment | 9 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Apr 18, 2005 |
| Last update posted | Jun 22, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: